Tze-Woei Tan | Healthcare Data Analysis | Best Researcher Award

Dr. Tze-Woei Tan | Healthcare Data Analysis | Best Researcher Award

University of Southern California | United States

Dr. Tze-Woei Tan is an Associate Professor of Clinical Surgery at the Keck School of Medicine of USC and Director of the Limb Salvage Research Program. He obtained his MBBS at the University of Melbourne (2002), completed general surgery training at Brown University (2010) and a vascular surgery fellowship at Boston University School of Medicine (2012), and later earned a Master of Public Health in Health Promotion (2020). His academic career includes an Assistant Professorship at the Louisiana State University Health Science Center (2012-16) and an Associate Professorship at the University of Arizona College of Medicine (2020-22) before his current role at USC. His research focuses on health services, access to care, health equity, and particularly limb preservation in patients with diabetes and peripheral artery disease, securing major NIH and foundation-funded grants in these areas. Among his recognitions are the Roger Pecoraro Award (American Diabetes Association, 2023) and the Faculty Teaching Award at Keck (2024). According to publicly available data his publication record spans from 2007 to 2025 and he is credited with an h-index of ~25, around 2,597 citations, and approximately 124 documents (note: bibliometric values vary by database and may be approximate). In sum, Dr. Tan merges specialist operative vascular surgery with a strong public-health and equity orientation, leading interdisciplinary efforts to reduce amputations and improve vascular care in underserved populations.

Profiles : Scopus | Orcid

Featured Publications

Bolakale-Rufai, I.K., French, S.R., Knapp, S.M., Thompson, M., Arias, J.C., Garcia-Filion, P., Ainapurapu, B., Tan, T.-W., & Weinkauf, C.C. (2025). “Stratification of Clinical Microvascular Disease Severity Using Non-Invasive Monofilament Testing in Patients with Type 2 Diabetes Mellitus” in Diabetology, 6(4). DOI: 10.3390/diabetology6040024.

Luu, I.Y., Hong, A.T., Lee, A., Arias, J.C., Shih, C.-D., Armstrong, D.G., & Tan, T.-W. (2024). “Improved Diabetic Foot Ulcer Outcomes in Medicaid Beneficiaries with Podiatric Care Access” in Diabetology, 5(5). DOI: 10.3390/diabetology5050036.

Kwon, K., Brown, T.A., Arias Aristizábal, J.C., Armstrong, D.G., & Tan, T.-W. (2024). “Outcomes for Patients with Diabetic Foot Ulcers Following Transition from Medicaid to Commercial Insurance” in Diabetology, 5(3). DOI: 10.3390/diabetology5030027.

Finco, M.G., Cay, G., Lee, M., Garcia, J., Salazar, E., Tan, T.-W., Armstrong, D.G., & Najafi, B. (2023). “Taking a Load Off: User Perceptions of Smart Offloading Walkers for Diabetic Foot Ulcers Using the Technology Acceptance Model” in Sensors, 23(5), 2768. DOI: 10.3390/s23052768.

Tan, T.-W., Armstrong, D.G., & collaborators. (2022). “Rates of Diabetes-Related Major Amputations Among Racial and Ethnic Minority Adults Following Medicaid Expansion Under the Patient Protection and Affordable Care Act” in JAMA Network Open, 5(3), e223991. DOI: 10.1001/jamanetworkopen.2022.3991. PMID: 35323948.

Kifah Hussain | Machine Learning and AI Applications | Best Researcher Award

Dr. Kifah Hussain | Machine Learning and AI Applications | Best Researcher Award

Northwestern University | United States

Dr. Kifah Hussain is a highly accomplished cardiologist specializing in advanced cardiovascular imaging and cardiovascular disease, currently completing a fellowship in Advanced Cardiovascular Imaging at Northwestern Memorial Hospital, Chicago. He previously completed a fellowship in Cardiovascular Disease at University of Chicago (Endeavor Health – Northshore) and an Internal Medicine residency at John H. Stroger Hospital of Cook County. Dr. Hussain earned his medical degree from Jawaharlal Nehru Medical College, India, and holds multiple board certifications, including Internal Medicine, Cardiovascular Disease, Nuclear Cardiology, and Adult Echocardiography. With a prolific research portfolio comprising over 30 peer-reviewed articles, book chapters, and abstracts, Dr. Hussain’s work focuses on echocardiography, cardiac CT imaging, transcatheter valve interventions, hypertrophic cardiomyopathy, cardiac amyloidosis, and AI-driven cardiovascular diagnostics. He has presented extensively at national and international conferences, contributed as a peer reviewer for JACC journals, and served as a mentor for cardiology fellows. Recognized for his academic and clinical excellence, he has received awards including the ASE Top 50 Early Career Investigators, multiple ACC and ASE travel and research grants, and departmental honors. Dr. Hussain’s contributions encompass over 17 documents, with an h-index of 7 and more than 123 citations. His work continues to advance cardiac imaging, structural heart interventions, and precision cardiology, reflecting a commitment to innovative research, clinical excellence, and education.

Profiles : Orcid | Scopus

Featured Publications

Hussain, K., Lee, K., Balasubramanian, S.S., Singh, L., Vyas, N., Hussain, F., Wathen, L., Ricciardi, M.J., Leipsic, J., Rogers, C., et al. (2025). “Prognostic value of coronary CTA-based AI plaque quantification in patients undergoing transcatheter aortic valve implantation.” European Journal of Radiology.

Hussain, K., Saleh, D., Tang, M., Garcia, C., Kislitsina, O., Meng, Z., Baldridge, A., Puthumana, J.J., Cremer, P.C., Rigolin, V.H., et al. (2025). “Effect of Mavacamten on serial speckle-tracking strain in patients with hypertrophic cardiomyopathy.” Journal of the American Society of Echocardiography.

Lee, K., Hussain, K., Ding, C., Tarchala, D., Rosenberg, J., Pursnani, A. (2025). “Utility of multimodality imaging in superior anomalous pulmonary venous return with inferior sinus venosus defect.” JACC: Case Reports.

Hussain, K., Lee, K., Minga, I., Wathen, L., Balasubramanian, S.S., Vyas, N., Singh, L., Shetty, M., Rosenberg, J.R., Levisay, J.P., et al. (2025). “Real-world application of CCTA with CT-FFR for coronary assessment pre-TAVI: the CT2TAVI study.” The International Journal of Cardiovascular Imaging.

Hussain, K., Sam, R., Patel, R., Nso, N., Singh, L., Nazari, J., Rosenberg, J., Metzl, M., Wasserlauf, J. (2024). “Impact of moderate sedation on electrophysiology lab time for left atrial appendage occlusion using 4D-intracardiac echocardiography.” Journal of Cardiovascular Electrophysiology.

 

Beatriz Barquiel Alcalá | Qualitative Research | Best Research Article Award

Dr. Beatriz Barquiel Alcalá | Qualitative Research | Best Research Article Award

Hospital Universitario La Paz | Spain

Dr. Beatriz Barquiel Alcalá is a physician-scientist specializing in endocrinology and nutrition, with a clinical appointment since 2010 at Hospital Universitario La Paz in Madrid. She holds a Licentiate in Medicine and Surgery from the University of Granada (2005) and completed further training under RD 99/2011 at the Universidad Autónoma de Madrid in 2012. Over her career she has published widely on diabetes and pregnancy, gestational and pregestational diabetes, maternal weight gain, and metabolic outcomes, including contributions as corresponding author. Her work spans over 30 scientific articles (e.g. on glycemic control, gestational weight gain, twin versus singleton pregnancies, neonatal outcomes, continuous glucose monitoring) as well as book chapters on hypertensive disorders, exercise in gestational diabetes, and obesity in pregnancy. She has led or participated in multiple funded projects—among them randomized trials and studies on biomarker validation, dietary interventions in pregnancy, and predictors of glycemic control. She also undertook a research stay at Memorial Sloan Kettering (USA) in 2009–2010. Her research interests lie at the intersection of maternal–fetal medicine, diabetes, metabolic programming, and endocrinology innovations.

Profile : Scopus

Featured Publications

Aguilera-García, I., Barquiel-Alcalá, B., Vázquez-Pérez, P., Prados-Sánchez, M.C., & González-Pérez de Villar, N. (2025). Time to change guidelines? Suboptimal glycemic control measures by CGM associated with cystic fibrosis exacerbations despite adequate HbA1c. Acta Diabetológica.

Borrego Soriano, I., Barquiel-Alcalá, B., Moreno-Domínguez, O., Qasem Moreno, A.L., García-Pérez de Sevilla, E., & González-Pérez de Villar, N. (2025). Screening system for the detection of unknown or poorly controlled diabetes mellitus in a tertiary hospital: A retrospective study. Journal of Evaluation in Clinical Practice.

Quirós, C., Herrera, M.T., Amigó, J., Perea, V., Barquiel, B., et al. (2024). Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by type 1 diabetes. Diabetes Technology & Therapeutics.

Barquiel, B. (AC), Calvo, M., Moreno-Domínguez, O., Bartha, J.L., et al. (2023). The PREDG study: A randomised controlled trial testing whether an educational intervention can prevent gestational weight gain in women with obesity. Clinical Nutrition ESPEN.

García-Moreno, C., Benítez-Valderrama, P., Barquiel, B., González-Pérez de Villar, N., Hillman, N., Lora Pablos, A., & Herranz, L. (2022). Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials. Diabetic Medicine.

 

Alexia Iasonos | Algorithm Development | Best Researcher Award

Dr. Alexia Iasonos | Algorithm Development | Best Researcher Award

Memorial Sloan-Kettering Cancer Center | United States

Dr. Alexia E. Iasonos is a recognized expert in biostatistics, currently a Member at Memorial Sloan Kettering Cancer Center where she serves as Director of Clinical Research Development. She earned her B.S. in Mathematics & Statistics from the University of Cyprus (1992-96), followed by an M.S. in Biometry & Statistics and a Ph.D. in Biometry & Statistics from SUNY Albany (awarded in 1998 and 2002 respectively). Her professional trajectory includes roles in academic statistics, pharmaceutical industry, and extensive hospital-affiliated clinical trial biostatistics. Her methodological research focuses on design and analysis of clinical trials, especially Bayesian adaptive Phase I and II designs, dose-finding methods, dose-expansion cohort development, predictive modeling and nomograms, biomarker evaluation and endpoints, particularly in gynecologic oncology. Her work has been instrumental in improving early drug development processes. According to AD Scientific Index, her h-index is 52, with over 10,779 total citations. She is an elected Fellow of the Society of Clinical Trials, deputy editor of Journal of Clinical Oncology, member/chair in several protocol and monitoring committees. Among her awards are those tied to leadership in early-phase trial methodology and contributions to cancer biostatistics. In conclusion, Dr. Iasonos continues to make high impact contributions in biostatistics and oncology by combining rigorous methodology with translational collaboration.

Profile : Scopus

Featured Publications

Iasonos, A. (2024). Evaluation of early phase dose finding algorithms in heterogeneous populations. Journal of Statistical Planning and Inference.

Iasonos, A. (2023). Controlled amplification in oncology dose-finding trials. Contemporary Clinical Trials.

Iasonos, A. (2022). Stopping rules for phase I clinical trials with dose expansion cohorts. Statistical Methods in Medical Research.

Iasonos, A. (2021). Controlled backfill in oncology dose-finding trials. Contemporary Clinical Trials.

Iasonos, A. (2021). Phase I clinical trials in adoptive T-cell therapies. Journal of the Royal Statistical Society: Series C (Applied Statistics).

George Vithoulkas – analysis of medical data – Excellence in Research 

Prof. George Vithoulkas - analysis of medical data - Excellence in Research 

University of the Aegean - Greece

Author Profile

Early Academic Pursuits

Prof. George Vithoulkas embarked on his academic journey with a fervent dedication to reviving and advancing the field of homeopathy. Born in Greece, his pursuit of knowledge in the domain of homeopathic medicine began over six decades ago. His early academic pursuits were marked by an insatiable curiosity and an unwavering commitment to the principles laid down by Samuel Hahnemann, the founder of homeopathy. Vithoulkas delved deep into understanding the intricacies of homeopathic philosophy and methodology, laying the foundation for his future endeavors.

Professional Endeavors

Throughout his illustrious career, George Vithoulkas emerged as a leading authority in homeopathic medicine, transcending geographical boundaries to spread awareness and knowledge. His professional endeavors were characterized by an unparalleled dedication to education and practice. Vithoulkas pioneered a teaching methodology that emphasized practical learning, allowing students to witness live cases and follow-ups, thereby enriching their understanding of classical homeopathy. As a professor at esteemed institutions worldwide, including the University of the Aegean and the State Medical University of Chuvash Republic, Russia, Vithoulkas imparted invaluable insights to aspiring homeopaths.

Contributions and Research Focus

Prof. Vithoulkas's contributions to the field of medicine and homeopathy are multifaceted and profound. He elucidated concepts such as the Levels of Health and the Continuum of a Unified Theory of Diseases, providing a comprehensive framework for understanding health and disease. His research delved into the transmutation of acute inflammatory conditions into chronic diseases, challenging conventional medical paradigms. Through seminal works like "The Science of Homeopathy" and "The New Model for Health and Disease," Vithoulkas reshaped the discourse on holistic healing. Moreover, his development of the Vithoulkas Expert System (VES) and the Vithoulkas Compass revolutionized homeopathic practice, making it more accessible and efficient.

Accolades and Recognition

Prof. Vithoulkas's groundbreaking contributions have garnered widespread acclaim and recognition on both national and international levels. He has been honored with prestigious awards, including the Right Livelihood Award, also known as the Alternative Nobel Prize, for his outstanding contributions to homeopathic knowledge and education. Recognized as the "Homeopath of the Millennium" by the Minister of Health in India, Vithoulkas's influence extends far beyond conventional boundaries. His honorary professorships at esteemed universities worldwide and his induction as an Honorary Fellow of the Faculty of Homeopathy, UK, underscore the magnitude of his impact on the medical community.

Impact and Influence

Prof. George Vithoulkas's influence extends beyond academia, shaping the practice of homeopathy and the perception of holistic medicine globally. His teachings have empowered generations of homeopaths to embrace classical principles and fostered a deeper understanding of the human condition. By advocating for the integration of homeopathy into mainstream medical education, Vithoulkas has paved the way for a more inclusive approach to healthcare. His advocacy efforts at international forums, including the World Health Organization and the European Parliament, have elevated the status of homeopathy and garnered institutional support.

Legacy and Future Contributions

As George Vithoulkas continues to inspire and educate, his legacy as a pioneering figure in homeopathic medicine remains unparalleled. His profound insights and innovative methodologies have left an indelible mark on the field, shaping its trajectory for years to come. With an unwavering commitment to excellence and a passion for advancing homeopathic knowledge, Vithoulkas's future contributions hold the promise of further enriching the practice and understanding of holistic healing. Through his books, academic endeavors, and ongoing research, he continues to champion the cause of classical homeopathy, ensuring its enduring relevance in the modern medical landscape.

Notable Publication

Elshaimaa Arafa – New medication Award – Women Researcher

Prof. Elshaimaa Arafa - New medication Award - Women Researcher

Ajman University of Science and Technology - United Arab Emirates

Author Profile

Early Academic Pursuits

Prof. El-Shaimaa A. Arafa, Ph.D., embarked on her academic journey with a Bachelor's degree in Pharmaceutical Sciences from Cairo University, where she graduated with honors and an exceptional GPA of 3.96 out of 4.0. This solid foundation in pharmaceutical sciences laid the groundwork for her subsequent achievements in academia.

Driven by a passion for advancing her knowledge and skills, Prof. Arafa pursued a Master's degree in Pharmacology and Toxicology from Cairo University, where she conducted research on the effectiveness of gastropathy-preventing drugs. Her dedication to research excellence led her to achieve a Master's degree with distinction.

Building upon her Master's studies, Prof. Arafa ventured into the realm of international education and research collaboration. She pursued a Ph.D. in Pharmacology, a joint program between Cairo University in Egypt and The Ohio State University in the USA. Her doctoral research focused on elucidating the molecular mechanisms underlying the modulatory effects of naturally occurring compounds on cancer therapy efficacy. This interdisciplinary approach underscored her commitment to addressing complex biomedical challenges.

During her academic journey, Prof. Arafa also completed pre-master courses at Cairo University, ensuring a comprehensive understanding of foundational subjects such as Statistics, Computer Sciences, and English Language, alongside specialized coursework in Pharmacology and Toxicology.

Professional Endeavors

Prof. Arafa's professional journey spans various academic positions and research roles, reflecting her versatility and expertise in pharmacology and toxicology. She has held teaching and research positions at esteemed institutions such as Beni-Suef University in Egypt, Taif University in Saudi Arabia, and Ajman University in the United Arab Emirates (UAE).

Her academic appointments include Assistant, Associate, and Professor positions, demonstrating her progressive leadership in academia. Prof. Arafa's contributions extend beyond traditional teaching roles; she has actively participated in curriculum development and course instruction for both graduate and undergraduate pharmacy students. Her diverse teaching portfolio encompasses courses ranging from basic pharmacology to specialized topics such as drug interactions and clinical pharmacology.

In addition to her teaching responsibilities, Prof. Arafa has made significant contributions to scientific research in pharmacology and toxicology. Her research expertise spans cancer biology, cell signaling, oxidative stress, and molecular mechanisms of drug action. Dr. Arafa has published extensively in reputable peer-reviewed journals, with her research findings contributing to advancements in cancer therapy, drug safety, and pharmacological interventions.

Contributions and Research Focus On New medication Award

Prof. Arafa's research endeavors have primarily focused on elucidating the molecular mechanisms of natural compounds in cancer therapy and oxidative stress-related disorders. Her pioneering work has shed light on the potential therapeutic applications of natural products in mitigating chemotherapy-induced toxicities, oxidative stress, and inflammation.

One of her notable research contributions includes investigating the protective effects of various natural compounds against chemotherapy-induced testicular injury, cardiac effects, and pulmonary fibrosis in preclinical models. Through a multidisciplinary approach encompassing in vitro and in vivo studies, Prof. Arafa has delineated the intricate signaling pathways involved in the pharmacological actions of these compounds.

Furthermore, Prof. Arafa's research has implications for drug development and translational medicine, emphasizing the importance of harnessing the therapeutic potential of natural compounds for combating clinical disorders. Her investigations into the pharmacological properties of medicinal plants and herbs have provided valuable insights into novel therapeutic targets and drug discovery strategies.

Accolades and Recognition

Prof. Arafa's exemplary contributions to academia and research have been recognized through various accolades and awards. She has received prestigious honors such as the Faculty Excellence in Research award from Ajman University and the Best Research Award from Beni-Suef University. Her research findings have been acknowledged internationally, with awards for best professional posters and presentations at renowned conferences such as the Dubai International Pharmaceuticals and Technologies Conference (DUPHAT).

Additionally, Prof. Arafa has been the recipient of fellowships and grants, including the BioVision Nxt Fellowship Award, which enabled her participation in the international Life Sciences Forum in Lyon, France. These accolades underscore her outstanding achievements and the significance of her research contributions in the field of pharmacology and toxicology.

Impact and Influence

Prof. Arafa's scholarly endeavors have made a profound impact on both academic scholarship and clinical practice. Her research publications have been widely cited within the scientific community, indicating the significance of her findings in advancing pharmacological knowledge and clinical therapeutics.

Moreover, Prof. Arafa's commitment to mentorship and academic leadership has fostered the development of future generations of pharmacologists and researchers. Through her mentorship programs and educational initiatives, she has inspired and guided aspiring scholars to pursue excellence in pharmaceutical sciences and biomedical research.

Legacy and Future Contributions

As a respected educator, researcher, and mentor, Prof. Arafa's legacy extends far beyond her individual achievements. Her dedication to advancing pharmacological research and promoting scientific innovation has left an indelible mark on the academic community.

Looking ahead, Prof. Arafa continues to explore new frontiers in pharmacology and toxicology, with a focus on translational research and personalized medicine. Her ongoing efforts to bridge the gap between basic science discoveries and clinical applications hold promise for addressing unmet medical needs and improving patient outcomes.

In summary, Prof. El-Shaimaa A. Arafa's remarkable academic pursuits, groundbreaking research endeavors, and enduring commitment to excellence exemplify her as a trailblazer in the field of pharmacology and toxicology. Through her visionary leadership and impactful contributions, she continues to shape the future of pharmacological research and inspire the next generation of scientists.

Citations

  • Citations   2317
  • h-index       26
  • i10-index    40

Notable Publication

 

 

Pasquale Viggiano – Ophthalmology – Young Scientist Award 

Assoc Prof Dr. Pasquale Viggiano - Ophthalmology - Young Scientist Award 

University of Bari: Universita degli Studi di Bari Aldo Moro - Italy

Author Profile

Early Academic Pursuits

Assoc Prof Dr. Pasquale Viggiano began his academic journey with a solid foundation in medicine, graduating from the Catholic University of Sacred Heart in Rome in 2015. During his undergraduate years, he engaged in clinical and research electives, demonstrating a keen interest in ophthalmology. His early exposure to the field provided him with valuable insights and experiences, laying the groundwork for his future endeavors.

Professional Endeavors

After completing his medical degree, Viggiano pursued further specialization in ophthalmology, undertaking a residency program at the University G. D'Annunzio Chieti-Pescara from 2016 to 2020. Under the guidance of esteemed mentors such as Prof. Leonardo Mastropasqua and Prof. Paolo Carpineto, he honed his skills and deepened his understanding of ocular health and diseases.

Following his residency, Viggiano embarked on fellowships and research positions to broaden his expertise. He completed a fellowship in cataract surgery at the Eye Research Center and Dr. Agarwal's Eye Hospital, further enhancing his surgical proficiency. Subsequently, he held researcher positions at prestigious institutions like the IRCCS-Fondazione Bietti in Rome and the University of Bari "Aldo Moro."

Contributions and Research Focus

Assoc Prof Dr. Viggiano's contributions to ophthalmic research are extensive and impactful. His publications cover a wide array of topics ranging from retinal imaging and vascular changes in age-related macular degeneration to innovative approaches in cataract surgery and anterior capsule contraction syndrome management. Through his collaborative efforts, he has advanced the understanding of various ocular conditions and contributed valuable insights to the scientific community.

His research focus revolves around utilizing advanced imaging techniques such as optical coherence tomography angiography (OCTA) to investigate retinal and choroidal vascular changes in ocular diseases. By elucidating the pathophysiology of these conditions, Viggiano aims to improve diagnostic accuracy and therapeutic interventions, ultimately enhancing patient outcomes.

Accolades and Recognition

Assoc Prof Dr. Viggiano's exceptional contributions have garnered recognition within the ophthalmic community. His co-authored publications have been featured in esteemed journals, reflecting the high quality and significance of his research endeavors. Additionally, his collaborative efforts with renowned clinicians and researchers underscore his standing as a respected figure in the field.

Impact and Influence

Assoc Prof Dr. Viggiano's work has made a significant impact on both clinical practice and academic discourse. By elucidating novel insights into ocular pathologies and treatment modalities, he has influenced clinical decision-making and contributed to the development of innovative therapeutic approaches. Furthermore, his publications serve as valuable educational resources for ophthalmologists and researchers worldwide, shaping the future direction of ocular research and patient care.

Legacy and Future Contributions

As a dedicated clinician-scientist, Viggiano's legacy lies in his commitment to advancing the frontiers of ophthalmic knowledge and improving patient outcomes. His multifaceted approach, combining clinical expertise with cutting-edge research, paves the way for continued innovation and progress in the field. With a passion for discovery and a drive to make a difference, Viggiano is poised to leave a lasting imprint on ophthalmology, inspiring future generations to push the boundaries of scientific inquiry and clinical practice.

Notable Publication

Kirill Artemov | Best Researcher Award | Real-world Case Studies

Kirill Artemov - Sechenov University - Real-world Case Studies🏆

Dr Kirill Artemov : Real-world Case Studies

Professional profile:

Early Academic Pursuits:

Dr. Kirill Artemov, as evidenced by his publications, seems to have a specialization in orthopedic surgery, particularly focusing on foot and ankle surgery and related biomechanics. His academic journey likely began with foundational studies in medicine, possibly pursuing advanced training or residencies in orthopedic surgery or related fields. The specific details of his early academic pursuits, such as where he studied or any significant mentors, are not provided in the information given but can be inferred from his specialized publications.

Professional Endeavors:

Dr. Artemov's professional endeavors are reflected in his notable publications within a short time frame. His work indicates an active engagement in clinical research, focusing on innovative surgical techniques and treatments related to foot and ankle pathology. These endeavors suggest a dedication to advancing the field of orthopedic surgery through evidence-based practices and contributions to scholarly journals such as the Journal of Foot and Ankle Surgery and International Orthopaedics.

Contributions and Research Focus:

Dr. Artemov's research and contributions primarily revolve around surgical treatments and biomechanics of foot and ankle disorders. His publications provide insights into innovative surgical techniques like modified Helal osteotomy with screw fixation and surgical treatments for conditions like metatarsalgia and severe instability of lesser metatarsophalangeal joints. His work suggests a commitment to enhancing patient outcomes through surgical innovation, biomechanical understanding, and evidence-based practices.

Accolades and Recognition:

The provided information does not specify any accolades or recognition for Dr. Artemov. However, his publications in reputable journals like the Journal of Foot and Ankle Surgery and International Orthopaedics indicate recognition within the academic and clinical communities. Recognition in the form of awards, grants, or other professional accolades would provide further insight into his contributions and standing within the field.

Impact and Influence:

Dr. Artemov's work has the potential to impact the field of orthopedic surgery significantly. His research on surgical treatments and biomechanics could influence clinical practices, surgical techniques, and patient outcomes related to foot and ankle disorders. By publishing in reputable journals, he contributes to the broader body of knowledge, fostering collaboration, and stimulating further research in this specialized area.

Legacy and Future Contributions:

While it is premature to assess Dr. Artemov's long-term legacy based on the provided information, his early contributions suggest a promising career trajectory in orthopedic surgery and research. As he continues to advance in his professional journey, his focus on innovative surgical techniques and biomechanical understanding will likely shape future practices, contribute to advancements in foot and ankle surgery, and influence the training and education of future orthopedic surgeons.

In summary, Dr. Kirill Artemov's early publications highlight his specialization in orthopedic surgery, particularly in foot and ankle pathology and biomechanics. His contributions reflect a commitment to advancing the field through innovative surgical techniques, research, and evidence-based practices, with the potential to impact patient outcomes and shape future practices in orthopedic surgery.